… of Early Response to a Single Dose of Asparaginase in Childhood Acute Lymphoblastic Leukemia. -
BL Asselin, S Kreissman, DJ Coppola, SD Bernal, PR … - Journal of Pediatric Hematology Oncology, 1999 - jpho-online.com
... Enzon, South Plainfield, NJ, provided pegaspargase (Oncaspar). ... Therapy with Erwinia
L- asparaginase in children with acute leukemia after anaphylaxis to E ...

… of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer … -
VI Avramis, S Sencer, AP Periclou, H Sather, BC … - Blood, 2002 - bloodjournal.hematologylibrary.org
... and polyethylene glycol conjugated asparaginase for treatment of children with newly
diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer ...

The best way to use asparaginase in childhood acute lymphatic leukaemia-still to be defined? -
JPV Pinheiro, J Boos - British Journal of Haematology, 2004 - Blackwell Synergy
... IU/m 2 of the PEG asparaginase preparation Oncaspar TM ... induction remission rates
in childhood relapsed acute lymphoblastic leukemia: a Pediatric ...

… (Oncaspar (R)) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL) -
PA Dinndorf, J Gootenberg, MH Cohen, P Keegan, R … - The Oncologist, 2007 - theoncologist.com
... FDA Drug Approval Summary: Pegaspargase (Oncaspar?) for the First-Line Treatment
of Children with Acute Lymphoblastic Leukemia (ALL). ...

Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according … -
HJ Muller, L Loning, A Horn, D Schwabe, M Gunkel, … - British Journal of Haematology, 2000 - Blackwell Synergy
... intensity of one dose of 1000 U/m 2 BSA Oncaspar TM should ... and antibody formation
during l-asparaginase treatment of children and adults with acute leukemia . ...

… evaluate plasma anti-asparaginase IgG concentrations in patients with acute lymphoblastic leukemia -
B Wang, LJ Hak, MV Relling, CH Pui, MH Woo, MC … - Journal of Immunological Methods, 2000 - Elsevier
... been widely used to treat acute lymphoblastic leukemia ... reactions to asparaginase
in leukemia patients have ... CAMR, Salisbury, UK) and PEG (Oncaspar, Enzon, Inc ...

… crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma … -
B Wang, MV Relling, MC Storm, MH Woo, R Ribeiro, … - Leukemia, 2003 - nature.com
... to asparaginase does not impact treatment outcome of childhood acute lymphoblastic
leukemia. ... PubMed | ChemPort |; Oncaspar prescribing information ...

Drug monitoring of low-dose PEG-asparaginase (Oncaspartm) in children with relapsed acute … -
JP Vieira Pinheiro, HJ Muller, D Schwabe, M Gunkel … - British Journal of Haematology, 2001 - Blackwell Synergy
... into the German market, PEG-ASNase (Oncaspar?) was approved for ... to Erwinia
asparaginase in children with acute lymphoblastic leukemia who had ...

… induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia -
D Douer, H Yampolsky, LJ Cohen, K Watkins, AM … - Blood, 2007 - bloodjournal.hematologylibrary.org
... a standard component in most treatment protocols for acute lymphoblastic leukemia
(ALL), 1 ... Pegaspargase (Oncaspar) is a modified form of native E ...

… on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia -
C Rizzari, M Citterio, M Zucchetti, V Conter, R … - Haematologica, 2006 - haematologica.org
... Acute Lymphoblastic Leukemia ? Research Paper ... The study drug was pegylated E.
coli asparaginase (Oncaspar ?, Medac GmbH, Hamburg, Germany ...